Metraipolis › archive › dc_692c67eca607
Prevalence of ocular Chlamydia trachomatis infection and antibodies within districts persistently endemic for trachoma, Amhara, Ethiopia — Europe PMC PMID:40067808
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40067808
- DOI
- 10.1371/journal.pntd.0012900
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T13:17:12.815Z
- SHA-256 of the archived text
09e9a062ce27c622e567eebd16911d0a844d8c64fd9f2e7365fd80243de4c644- Stable URL of this page
https://metraipolis.com/documento/dc_692c67eca607
How to cite
Prevalence of ocular Chlamydia trachomatis infection and antibodies within districts persistently endemic for trachoma, Amhara, Ethiopia — Europe PMC PMID:40067808 — Europe PMC (en), https://europepmc.org/article/MED/40067808 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_692c67eca607 (Metraipolis archive dc_692c67eca607, sha256 09e9a062ce27c622e567eebd16911d0a844d8c64fd9f2e7365fd80243de4c644)
BibTeX
@misc{dc692c67eca607,
title = {Prevalence of ocular Chlamydia trachomatis infection and antibodies within districts persistently endemic for trachoma, Amhara, Ethiopia — Europe PMC PMID:40067808},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40067808},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_692c67eca607; sha256 09e9a062ce27c622e567eebd16911d0a844d8c64fd9f2e7365fd80243de4c644},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/40067808. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Persistent trachoma is increasingly recognized as a serious concern for the global trachoma program. Persistent trachoma is defined as those districts that have had two or more trachoma impact surveys in which the trachomatous inflammation-follicular (TF) prevalence has never been 10 years of interventions. Methodology: Population-based surveys were conducted in 2019 in four trachoma persistent districts. Children ages 1-9 years were examined for trachoma clinical signs and children 1-5 years were swabbed for Ct infection. Antibodies to the trachoma antigens Pgp3 and CT694 were measured for all individuals ≥1 year, assessed by multiplex bead assay. Seroconversion rates (SCRs) to both antigens were estimated for children and for individuals of all ages. Results: One district, Ebinat, remained highly endemic, with a TF prevalence and infection prevalence (ages 1-5 years) of 42.5% and 7.1% respectively. Indicators were lower in the other three districts ranging from 10.7%-17.9% TF and 0%-1.7% infection. The Pgp3 SCR among children ages 1-9 years was considerably higher in Ebinat with 10.8 seroconversions per 100 child-years, (95% Confidence Interval [CI]: 8.2, 14.4) compared to the other three districts (SCR range: 0.9-3.9). All-age Pgp3 SCR estimates detected a significant decline in seroprevalence in Machakel district at approximately 12 years prior to 2019. Conclusions: Infection and serology may be useful tools for clarifying transmission, particularly among persistent districts, and ongoing interventions likely helped push these hyperendemic districts towards the elimination threshold. However, districts such as Ebinat may require more intense interventions to reach elimination within acceptable timelines. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS neglected tropical diseases, 2025 (prima pubblicazione 2025-03-11). Identificativi: PMID 40067808 · PMCID PMC11936273 · DOI 10.1371/journal.pntd.0012900. Descrittori MeSH principali: Chlamydia trachomatis; Trachoma; Antibodies, Bacterial. Pagina: https://europepmc.org/article/MED/40067808 — https://doi.org/10.1371/journal.pntd.0012900. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T11:32:36.049Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.